Li et al. demonstrated that coadministration of carbonic anhydrase IX (CAIX)-CAR-T cells with Sunitinib significantly enhanced therapeutic efficacy against a mouse model of human metastatic renal cancer and resulted in prolonged survival of mice, as well as reduction in the number of MDSCs at the cancer site (246). This evidence concerns the gene CA9 and cancer.